Laurens J L De Cocker1,2, A Compter3, L J Kappelle3, P R Luijten4, J Hendrikse4, H B Van der Worp3. 1. Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands. laurens_de_cocker@hotmail.com. 2. Kliniek Sint-Jan Radiologie, Kruidtuinlaan 32, 1000, Brussels, Belgium. laurens_de_cocker@hotmail.com. 3. Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands. 4. Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Abstract
INTRODUCTION:Cerebellar cortical infarct cavities are a newly recognised entity associated with atherothromboembolic cerebrovascular disease and worse physical functioning. We aimed to investigate the relationship of cerebellar cortical infarct cavities with symptomatic vertebrobasilar ischaemia and with vascular risk factors. METHODS: We evaluated the MR images of 46 patients with a recent vertebrobasilar TIA or stroke and a symptomatic vertebral artery stenosis≥50 % from the Vertebral Artery Stenting Trial (VAST) for the presence of cerebellar cortical infarct cavities ≤1.5 cm. At inclusion in VAST, data were obtained on age, sex, history of vertebrobasilar TIA or stroke, and vascular risk factors. Adjusted risk ratios were calculated with Poisson regression analyses for the relation between cerebellar cortical infarct cavities and vascular risk factors. RESULTS:Sixteen out of 46 (35 %) patients showed cerebellar cortical infarct cavities on the initial MRI, and only one of these 16 patients was known with a previous vertebrobasilar TIA or stroke. In patients with symptomatic vertebrobasilar ischaemia, risk factor profiles of patients with cerebellar cortical infarct cavities were not different from patients without these cavities. CONCLUSION:Cerebellar cortical infarct cavities are seen on MRI in as much as one third of patients with recently symptomatic vertebral artery stenosis. Since patients usually have no prior history of vertebrobasilar TIA or stroke, cerebellar cortical infarct cavities should be added to the spectrum of common incidental brain infarcts visible on routine MRI.
RCT Entities:
INTRODUCTION:Cerebellar cortical infarct cavities are a newly recognised entity associated with atherothromboembolic cerebrovascular disease and worse physical functioning. We aimed to investigate the relationship of cerebellar cortical infarct cavities with symptomatic vertebrobasilar ischaemia and with vascular risk factors. METHODS: We evaluated the MR images of 46 patients with a recent vertebrobasilar TIA or stroke and a symptomatic vertebral artery stenosis ≥50 % from the Vertebral Artery Stenting Trial (VAST) for the presence of cerebellar cortical infarct cavities ≤1.5 cm. At inclusion in VAST, data were obtained on age, sex, history of vertebrobasilar TIA or stroke, and vascular risk factors. Adjusted risk ratios were calculated with Poisson regression analyses for the relation between cerebellar cortical infarct cavities and vascular risk factors. RESULTS: Sixteen out of 46 (35 %) patients showed cerebellar cortical infarct cavities on the initial MRI, and only one of these 16 patients was known with a previous vertebrobasilar TIA or stroke. In patients with symptomatic vertebrobasilar ischaemia, risk factor profiles of patients with cerebellar cortical infarct cavities were not different from patients without these cavities. CONCLUSION:Cerebellar cortical infarct cavities are seen on MRI in as much as one third of patients with recently symptomatic vertebral artery stenosis. Since patients usually have no prior history of vertebrobasilar TIA or stroke, cerebellar cortical infarct cavities should be added to the spectrum of common incidental brain infarcts visible on routine MRI.
Authors: Jacques L De Reuck; Vincent Deramecourt; Florent Auger; Nicolas Durieux; Charlotte Cordonnier; David Devos; Luc Defebvre; Caroline Moreau; Dominique Capparos-Lefebvre; Florence Pasquier; Didier Leys; Claude-Alain Maurage; Regis Bordet Journal: Cerebrovasc Dis Date: 2015-01-31 Impact factor: 2.762
Authors: Nolan S Hartkamp; Laurens J De Cocker; Michael Helle; Matthias J P van Osch; L Jaap Kappelle; Reinoud P H Bokkers; Jeroen Hendrikse Journal: Neuroimage Date: 2013-06-29 Impact factor: 6.556
Authors: Annette Compter; H Bart van der Worp; Wouter J Schonewille; Jan Albert Vos; Jelis Boiten; Paul J Nederkoorn; Maarten Uyttenboogaart; Rob T Lo; Ale Algra; L Jaap Kappelle Journal: Lancet Neurol Date: 2015-04-20 Impact factor: 44.182
Authors: Laurens J L De Cocker; Susanne J van Veluw; Geert Jan Biessels; Wim G M Spliet; Isabel E Thunnissen; Peter R Luijten; Jeroen Hendrikse; Jaco J M Zwanenburg Journal: Cerebrovasc Dis Date: 2014-08-27 Impact factor: 2.762
Authors: Sarah E Vermeer; Niels D Prins; Tom den Heijer; Albert Hofman; Peter J Koudstaal; Monique M B Breteler Journal: N Engl J Med Date: 2003-03-27 Impact factor: 91.245
Authors: Mariam Samim; Jeroen Hendrikse; H Bart van der Worp; Pierfrancesco Agostoni; Freek Nijhoff; Pieter A Doevendans; Pieter R Stella Journal: Clin Res Cardiol Date: 2015-01-18 Impact factor: 5.460
Authors: Laurens J L De Cocker; Raoul P Kloppenborg; Yolanda van der Graaf; Peter R Luijten; Jeroen Hendrikse; Mirjam I Geerlings Journal: Stroke Date: 2015-09-17 Impact factor: 7.914
Authors: A Compter; H B van der Worp; W J Schonewille; J A Vos; A Algra; T H Lo; W P Th M Mali; F L Moll; L J Kappelle Journal: Trials Date: 2008-11-24 Impact factor: 2.279
Authors: Laurens Jl De Cocker; Arjen Lindenholz; Jaco Jm Zwanenburg; Anja G van der Kolk; Maarten Zwartbol; Peter R Luijten; Jeroen Hendrikse Journal: Neuroimage Date: 2016-11-18 Impact factor: 6.556